Patents by Inventor Thomas Steenstrup

Thomas Steenstrup has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Glycosylation-Disrupted Factor VII Variants
    Publication number: 20080058255
    Abstract: The present invention relates to human coagulation Factor VII polypeptides, as well as polynucleotide constructs encoding such polypeptides, vectors and host cells comprising and expressing the polynucleotide, pharmaceutical compositions comprising Factor VII polypeptides, uses and methods of treatment; and any additional inventive features related thereto.
    Type: Application
    Filed: June 17, 2005
    Publication date: March 6, 2008
    Applicant: Novo Nordisk HealthCare A/G
    Inventors: Gert Bolt, Thomas Steenstrup, Claus Kristensen
  • TF binding compounds
    Publication number: 20060024730
    Abstract: The present invention relates to novel compounds that bind to and inhibit the activity of tissue factor (TF) and mediate a cytolytic immune response.
    Type: Application
    Filed: September 15, 2005
    Publication date: February 2, 2006
    Applicant: Novo Nordisk A/S
    Inventors: Soren Bjorn, Else Nicolaisen, Thomas Steenstrup